Individuals Discontinuing Anti-Obesity Jabs Put On Pounds Far More Rapidly Compared to Those on Conventional Diets

Fresh analysis suggests that patients who stop using new GLP-1 drugs like Mounjaro or Wegovy can put back on lost weight far faster than those who stop conventional lifestyle programs.

Research printed in a prominent health publication demonstrates that while obese individuals often shed a large proportion of their total mass while using the jabs, the mass comes back at an average rate of 0.8 kg per month after stopping.

"Individuals using these drugs should be cognizant of the potential of quick weight regain when the treatment ends," stated expert Dr. Susan Jebb.

That rate of regain means a reversion to original weight in about a year and a half.

Weighing Treatments

The analysis, which looked at dozens of studies involving thousands of participants, compared the outcomes of these new drugs with older methods.

Researchers point out that people who shed pounds through dieting usually experience a less rapid weight regain—around 0.1 kg a month—post-intervention.

Understanding the Fast Rebound

Doctors suggest the way of the drugs explains the heightened regain.

These medications imitate a body's own chemical called GLP-1, which helps regulate hunger.

"Long-term administration of GLP-1 concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.

"Withdrawal of this GLP-1 'fix' results in hunger is unsuppressed, making overeating far more likely."

A Chronic Disease?

Health authorities recommend the injections for people with weight-linked health risks, accompanied by prescribed lifestyle changes.

Professionals say that, due to the likelihood of relapse, the treatment should be considered ongoing.

This perspective is echoed by pharmaceutical companies, who state that the findings "highlight the long-term character of obesity," akin to managing diseases like hypertension.

Patient Testimonies

Users who have stopped the medication describe a sudden return of cravings.

"It felt as if something flipping and you're instantly ravenous," described a patient.

This challenge is exacerbated if patients have not adopted sustainable lifestyle or habit changes during therapy.

Significant Adoption

Recent estimates show that a significant number of people in the UK have used these injections in the last 12 months, with desire being substantial.

• Adoption is more common among women compared to men.
• The middle-aged age group shows the highest level of interest.
• Many access the medications through private healthcare rather than public health services.

Ultimately, experts stress that while the jabs are powerful tools for weight loss, they are not a magic solution and lasting health benefits hinges on integrated behavioural support.